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Abstract 
The toughness of femoral atherosclerotic tissue is of pivotal importance to understanding the 
mechanism of luminal expansion during cutting balloon angioplasty (CBA) in the peripheral 
vessels. Furthermore, the ability to relate this parameter to plaque composition, pathological 
inclusions and location within the femoral vessels would allow for the improvement of 
existing CBA technology and for the stratification of patient treatment based on the predicted 
fracture response of the plaque tissue to CBA. Such information may lead to a reduction in 
clinically observed complications, an improvement in trial results and an increased adoption 
of the CBA technique to reduce vessel trauma and further endovascular treatment uptake. 
This study characterises the toughness of atherosclerotic plaque extracted from the femoral 
arteries of ten patients using a lubricated guillotine cutting test to determine the critical 
energy release rate. This information is related to the location that the plaque section was 
removed from within the femoral vessels and the composition of the plaque tissue, 
determined using Fourier Transform InfraRed spectroscopy, to establish the influence of 
location and composition on the toughness of the plaque tissue. Scanning electron 
microscopy (SEM) is employed to examine the fracture surfaces of the sections to determine 
the contribution of tissue morphology to toughness.  
Toughness results exhibit large inter and intra patient and location variance with values 
ranging far above and below the toughness of healthy porcine arterial tissue (Range: 1330 to 
3035 for location and 140 to 4560 J/m2 for patients). No significant difference in mean 
toughness is observed between patients or location. However, the composition parameter 
representing the calcified tissue content of the plaque correlates significantly with sample 
toughness (r = 0.949, p < 0.001). SEM reveals the presence of large calcified regions in the 
toughest sections that are absent from the least tough sections. Regression analysis highlights 
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the potential of employing the calcified tissue content of the plaque as a preoperative tool for 
predicting the fracture response of a target lesion to CBA (R2 = 0.885, p < 0.001). 
Keywords: femoral artery, atherosclerotic plaque, tissue characterisation, toughness, fracture, 
calcification, FTIR.  
PTA;   Percutaneous transluminal angioplasty 
BR;   Bifurcation region 
CBA;   Cutting balloon angioplasty 
CFA;   Common femoral artery 
DFA;   Deep femoral artery 
FTIR;    Fourier transform infrared  
SEM;   Scanning electron microscopy 
SFA;   Superficial femoral artery 
Ca:Tot;   Ratio of calcification to total measurable plaque content 
Col:Tot;   Ratio of collagen to total measurable plaque content  
Lip:Tot;   Ratio of lipid to total measurable plaque content 
EDX;   Energy-dispersive X-ray 
Ca:P;   Calcium to phosphorus ratio  
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1 Introduction 
The femoral arteries are one of the most susceptible vascular locations for the development of 
atherosclerosis. The occurrence of this disease process in these vessels is the leading cause of 
lifestyle-limiting claudication and ischemic rest pain [1]. Common femoral endarterectomy 
has been the standard treatment for focal occlusive disease of the femoral arteries for over 50 
years [2]. Numerous studies have examined the 5 year patency rates of this procedure and 
found them to range between 68% and 94% [3-5]. Further data examining the effectiveness 
of this procedure have suggested that it should remain the standard of care for atherosclerosis 
of the femoral arteries due to its safety and efficacy. However, despite the proven efficacy of 
this treatment modality, morbidity rates remain high (10 – 20%) due to its invasive nature and 
certain groups of patients are considered high risk for surgery [6, 7]. 
The use of Percutaneous Transluminal Angioplasty (PTA) has been advocated as a treatment 
alternative for patients at higher risk of surgical morbidity and mortality [7]. Despite this, the 
long term results for PTA in the femoral arteries are disappointing due to uncontrolled 
dissections in complex lesions, inadequate luminal expansion in rigid strictures and recurrent 
stenosis in the dilated segment [8-11]. PTA has also been shown to cause significant trauma 
to the plaque tissue [12] and stretching to the vessel wall [13]. This has been suggested as a 
major contributor to constrictive vascular remodelling and neointimal hyperplasia which are 
directly associated with restenosis [14]. Stent implantation for the treatment of femoral 
arterial lesions does address the issues of elastic recoil, residual stenosis, and flow-limiting 
dissection that are typically associated with PTA. This is achieved by the stent acting as a 
permanent implant therefore supporting the tissue. However, it does not substantially 
improve primary patency [15-17] due to exaggerated neointimal hyperplasia that leads to in-
stent restenosis in 20-40% of patients at 2 years [18, 19].  
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Drug eluting stents have been employed in the femoral arteries to address the issue of in-stent 
restenosis by delivering an anti-restenotic drug to the treated area. This approach has been 
shown to offer improved patency rates compared to PTA in the Zilver PTX trial [20]. 
However, drug eluting stents have failed to demonstrate a significant reduction in restenosis 
when compared to traditional stents in the SIROCCO I and II trials [19]. Furthermore, 
microfriction due to stent movement remains an issue after complete elution of the loaded 
drug. This can lead to vessel irritation, inflammation and ultimately restenosis [21]. 
Cutting Balloon Angioplasty (CBA) has been developed to alleviate the injury response 
observed following endovascular treatment using existing minimally invasive devices. The 
cutting balloon is a non-compliant balloon with 3 to 4 radially positioned microblades that 
incise the plaque and propagate a controlled fracture thereby reducing elastic recoil, vessel 
dilation, vessel injury, and subsequent restenosis compared with PTA [22-24]. Relatively low 
balloon pressures are recommended for use with CBA (4-8 atmospheres) that dilate the target 
vessel with reduced force to potentially decrease the risk of a neoproliferative response and 
restenosis. Numerous studies have demonstrated the safety and efficacy of CBA [24-29] and 
several reports highlight the possibility of CBA application in the peripheral arteries due to 
the relatively low restenosis rates observed during short-term follow-up [30-34] with one 
randomised controlled trial recently demonstrating the superiority of CBA over PTA [35]. 
The potential of CBA is based on a decrease in inflammatory response [36], a decrease in 
proliferative response [37], and an increase in plaque reduction with accompanying decrease 
in vessel stretch following CBA compared with PTA [13]. 
Despite these promising findings, a number of studies have observed low effectiveness of this 
method [38, 39] and two randomised controlled trials failed to demonstrate the superiority of 
CBA over PTA in both coronary and peripheral arteries [38, 40]. Various complications 
related to CBA have also been reported including arterial rupture, delayed perforation, and 
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fracture of microsurgical blades [41-43]. Arterial injury response to endovascular treatment 
varies significantly with plaque composition [44-46] and it has been previously stated that the 
mechanisms of CBA affected by plaque composition need to be clarified [47]. While the 
mechanical response of femoral plaque tissue to circumferential stretch has recently been 
characterised [48, 49], the toughness of this tissue remains unknown. Toughness measures 
the ability of a material to absorb energy prior to fracturing. This parameter is of pivotal 
importance to understanding the mechanism of luminal expansion during CBA. Furthermore, 
the ability to relate this parameter to plaque composition and pathological inclusions would 
allow for the improvement of existing CBA technology and for the stratification of patient 
treatment based on the predicted fracture response of the plaque tissue to CBA. Such 
information may lead to a reduction in clinically observed complications, an improvement in 
trial results and an increased adoption of the CBA technique to reduce vessel trauma and 
further endovascular treatment uptake. 
This study therefore characterises the toughness of atherosclerotic human tissue extracted 
from the femoral arteries using a lubricated guillotine cutting test to determine the critical 
energy release rate, a measure of toughness. This information is then related to the location 
that the plaque section was removed from within the femoral vessels, the composition of the 
plaque tissue as determined using Fourier Transform InfraRed (FTIR) spectroscopy, and the 
pathological inclusions identified using Scanning Electron Microscopy (SEM). 
2 Materials and Methods 
2.1 Patient Characteristics 
Following hospital ethical research committee approval, femoral plaque samples were 
gathered from 10 consecutive consenting patients undergoing common femoral 
endarterectomy to treat high grade arterial stenosis. Plaque samples were endarterectomised 
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in toto with preservation of plaque structural integrity when cutting along the longitudinal 
length of the specimen. Samples were taken from the hospital and frozen in phosphate buffer 
solution (Fisher Scientific, Product code: 12821680) at -20°C as this method of storage has 
been shown to have no significant effects on arterial tissue mechanical properties [50-52]. 
Prior to testing, samples were equilibrated to 37°C in fresh phosphate buffer solution and 
divided into 7mm wide sections for testing. Plaque sections are grouped based on their 
location within the femoral vessels i.e. common femoral artery (CFA), bifurcation region 
(BR), superficial femoral artery (SFA) or deep femoral artery (DFA), Figure 3a. This led to 
27 sections being obtained from the CFA, 10 from the BF, 5 from the SFA and 4 from the 
DFA. 
2.2 Mechanical Testing 
Several techniques are available to induce a controlled fracture during toughness testing, 
including tearing [53]; scissoring [54, 55]; and cutting [56, 57]. Considering the size and 
shape of the plaque samples obtained from endarterectomy, it was not feasible to perform 
tearing tests to evaluate toughness [58]. Scissor tests were not employed as the induced 
fracture advances in a mixed mode through the material which does not allow for a reliable 
estimation of toughness in Mode I [57].  
Recently, the damage energies of porcine aorta have been characterized by Chu et al. [58]. A 
similar custom-built device to that used in [58] is employed in the present study to measure 
the toughness of the human atherosclerotic tissue. This device employs a lubricated guillotine 
cutting test to assess the toughness of the atherosclerotic tissue under Mode I displacement 
controlled cut propagation, known to be the weakest fracture mode [59]. The cut is 
propagated along the axial direction as this is the direction that a cutting balloon attempts to 
cut during CBA. This method of testing characterises samples using the energy approach to 
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fracture mechanics and defines the toughness values generated in terms of critical energy 
release rate. 
2.2.1 Test System 
It has been previously demonstrated that the majority of blades indent the target substrate 
prior to cut initiation [55]. Furthermore, the extent of indentation can be significant 
depending on the substrate material and the condition of the blade. In an attempt to minimise 
initial indentation, the concept of the slice/push ratio introduced by Atkins et al. [60] and 
previously employed by Chu et al. [58] is implemented in this study. This ratio represents the 
magnitude s of a sideways horizontal motion (slicing) that the cutting blade undergoes per 
unit of vertical motion p (pushing). The motions of s and p are in-plane to the cut, and p is 
normal to the cut tip. A slice/push ratio of 3.5:1 is employed in this work [58]. This ratio is 
achieved by tilting both the sample and the blade by θ = 15.93° off the blade displacement (d) 
axis, Figure 1b. 
With the above considerations, the custom-designed guillotine toughness tester employed in 
the aforementioned study was built and adapted for this study, Figure 1. The blade holder is 
attached to a sliding arm on linear bearings. The blade holder is equally angled with respect 
to the sample holder. During testing, a sample is clamped across the slit to the flat surface 
using custom designed clamps that are tightened with four equispaced bolts, Figure 1. The 
clamps are lined with sand paper and designed to provide minimal clamping force that limits 
the movement of the sample in the p-direction during cutting without inducing noticeable 
compressive transverse stresses that may reduce the energy required to cut the section [55]. 
The slit is made as narrow as possible to prevent the sample from deforming out-of-plane in 
the s-direction as it is being dragged into the slit by the blade. At the closed end of the slit is a 
rubber block on which the sample is butted against to minimize sample deformation in the p-
direction. The sample holder is connected directly to an Omega LCFD miniature 12 N load 
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cell (Omega, Manchester, UK) which measures the force exerted by the blade on the sample 
as the blade moves through the sample. 
Figure 1: (a) Schematic of the experimental apparatus used to determine the toughness of the excised human femoral 
plaque samples and (b) slice-push ratio employed in this study. 
2.2.2 Test Process 
GEM single edge 0.23mm aluminium-back razor blades (Personna American Safety Razor 
Company, Cedar Knolls, USA) were used for testing. The aluminium backs of the blades are 
removed, leaving only the blades. Prior to experimental use, each blade is used to make 
twenty 7 mm deep cuts through silicone (Sylgard 187, Dow Corning, MI, USA) to stabilize 
the cutting edge. This “preconditioning” of the blades is necessary as Verhoeven et al. [61] 
demonstrated experimentally that the sharpness of a virgin blade edge decreases dramatically 
within a number of cuts before exhibiting a steady state of sharpness. 
A preconditioned razor blade is installed into the blade holder and lubricated with a 50% 
white spirit (Sigma-Aldrich, Wicklow, Ireland) / 50% light mineral oil (Sigma-Aldrich, 
Wicklow, Ireland) solution. Lubricant is used to limit the friction between the blade and the 
fracture surface. Friction must be minimised as the energy dissipated by the blade during 
cutting is the sum of the energy required to create the facture surface and the energy required 
to overcome frictional forces. The influence of friction is further reduced from the analysis by 
performing two successive cycles, as depicted in Figure 2. In the first cycle, the moving blade 
cuts the tissue with a blade velocity of 0.5 mm/s. The blade is then cleaned and re-lubricated. 
A second cycle is performed at the same velocity that passes the blade over the newly formed 
fracture surface. This estimates the friction force between the blade and the tissue surface 
[62]. The difference in the areas under the two curves yields the work required to cut the 
sample. 
Figure 2: Sample force-cut length curve obtained from guillotine testing of an atherosclerotic tissue section. 
  
 
10 
 
2.2.3 Data Analysis 
This method of testing measures the critical energy release rate, GC which is a measure of a 
material’s toughness. GC is determined by calculating the work, W performed by the blade in 
cutting the section and dividing this value by the newly created fracture surface area, A fracture. 
This equation is given by eqn. 1 and is measured in J/m2. 
 
 = 	
	
  (eqn. 1) 
To obtain the work required to create the fracture surface (W fracture), the work of the empty 
pass (W empty) is subtracted from that of the cutting pass (W cutting), such that: 
 
	
 =
		 −	 (eqn. 2) 
in which W cutting and W empty are obtained via the following equation:  
 
 = 3.64 	 (eqn. 3) 
where ds is the incremental displacement of the blade. The angle of the blade relative to the 
test section results in force being applied to the section at an angle of 74.7° to the 
displacement of the blade, Figure 1b. As work must be calculated parallel to the motion of the 
blade, it is necessary to multiply all force values by 3.64 in order to resolve the force into its 
component parallel to the motion of the blade. 
To calculate W cutting, F is equal to F cut in eqn. 3 which is the force exerted by the blade on 
the section to create the fracture. To calculate W empty, F is equal to F empty pass which is the 
force required to pass the blade through the newly created fracture surface following the 
initial cutting of the section. This measure provides an estimation of the work required to 
overcome the friction of the blade passing over the newly formed fracture surface while 
cutting the section. The integration in eqn. 3 is performed using the 3/8 Simpson’s rule [63]. 
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2.3 Composition Characterisation 
FTIR spectroscopy is an analytical technique that characterises the composition of a 
substance by quantifying the absorbance of infrared radiation by specific chemical function 
groups. This study employs FTIR spectroscopy to determine the composition of each plaque 
section following sample sectioning and guillotine testing, Figure 3a. Probe based attenuated 
total reflectance was performed on two to four locations along the luminal aspect of the 
fracture path to obtain a range of spectra (Spectrum 100, Perkin Elmer Inc MA, USA, 
diamond crystal). All spectra were ascertained using absorbance with a resolution of 2 cm-1 
and 8 scans over the range of 4000 – 700 cm-1. Following the subtraction of water from each 
spectrum [64], the areas under the key peaks of interest were measured (Lipid: 2980 – 2810 
cm-1, Lipid Ester: 1750 – 1715 cm-1, Collagen: 1715 – 1585 cm-1 and Calcification: 1180 – 
900 cm-1), Figure 3b. The average area under each of the peaks were summated and from 
this, the ratios of collagen (Col), lipid (Lip), and calcification (Ca) to the total measureable 
content (Tot) can be calculated. Lipid ester identified in samples is included with lipid in the 
Lip measure. This results in three composition parameters: Col:Tot, Lip:Tot and Ca:Tot, 
Figure 3b. These parameters allow for the relation between the composition and the 
toughness of atherosclerotic femoral arterial tissue to be determined. 
Figure 3: (a) Sample sectioning, guillotine testing and FTIR spectroscopic examination performed along the luminal 
aspect of the fracture path. (b) Sample spectra with peak-areas representing lipid, lipid ester, collagen and 
calcification content leading to the development of three composition parameters. 
2.4 Structural Analysis 
SEM analysis was performed to qualitatively examine the morphology of the plaque along 
the fracture surface of a number of plaque sections. As a conventional scanning electron 
microscope was used in this study, it was necessary to chemically prepare each sample using 
a process of fixation, chemical dehydration and drying to minimize damage and shrinkage to 
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the tissue structure during analysis [65, 66]. In order to achieve these criteria, a previously 
outlined SEM preparation procedure was employed [67]. The sections were initially cleaned 
in fresh phosphate buffer solution and then fixed in methanol (Fisher Scientific, Product 
code: 10020260) for 10 min. The fixed sections were then washed in ethanol prior to passing 
through seven ascending increments of molecular biology grade ethanol (99.5% (v/v)) (Fisher 
Scientific, Product code: 10644795) and distilled water mixtures (30% ethanol up to 100% 
ethanol in increments of 30, 50, 70, 80, 90 and 95% ethanol) for ten minutes at each 
increment. The sections were then chemically dried in a hexamethyldisilazane (Sigma-
Aldrich, Product code: 440191) and ethanol mixture (50:50) for 10 min prior to being 
transferred into 100% hexamethyldisilazane for 10 min to complete the drying process. The 
sections were then gold plated at 30 mA for 120 s using an Emitech K550 (Emitech Ltd. 
U.K.) to ensure electrical conductivity so as to produce clear and qualitative images. 
Energy-dispersive X-ray (EDX) spectroscopy (Oxford Instruments plc, UK) is employed in 
this study to confirm the presence of calcified tissue at the fracture surface of the plaque 
sections and investigate its chemical composition. EDX measurements were taken at the site 
of suspected calcified tissue during SEM imaging. The accelerating voltage was increased 
from 10 to 20 kV and a dead time of between 20% and 40% was applied during elemental 
analysis. The EDX analysis process was performed using INCA Energy software (Oxford 
Instruments plc, UK). Tissue was confirmed as calcified by identifying the presence of 
calcium and phosphorus within the target area and also by assessing the ratio of these two 
elements (Ca:P). 
2.5 Statistical Analysis 
Statistical analysis was performed using Minitab 17 (Minitab Inc State College, PA, USA). 
Correlations between the dependant and predictive variables were assessed using 2-tailed 
parametric and nonparametric bivariate analysis. Regression analysis was performed to 
  
 
13 
 
examine the relationship between the composition parameters and the toughness. One-way 
ANOVA tests with post hoc Bonferroni correction were performed to identify significant 
differences between mean plaque section toughness values grouped by patient and location. 
A p value of less than 0.05 was considered statistically significant.  
3 Results 
Table 1 displays the toughness and composition parameters of the 46 plaque sections 
obtained from the 10 patient vessels examined in this study. 
Table 1: The patient details, location of plaque section, toughness and composition parameters of all plaque sections 
examined in this study (M – male, F – female, R – right, L – left). 
Patient Gender Side Age Location Toughness Lip:Tot Col:Tot Ca:Tot 
1 M R 64 
CFA 4346.20 0.08 0.37 0.55 
CFA 1464.48 0.13 0.49 0.37 
CFA 3655.60 0.14 0.43 0.43 
CFA 1358.67 0.17 0.45 0.39 
CFA 4702.41 0.11 0.37 0.52 
BR 197.76 0.12 0.66 0.22 
SFA 86.50 0.31 0.50 0.18 
2 F L 71 
CFA 1811.12 0.24 0.36 0.40 
CFA 343.14 0.29 0.52 0.19 
CFA 357.96 0.38 0.38 0.24 
BR 1563.09 0.15 0.50 0.36 
DFA 2836.94 0.14 0.44 0.42 
3 F R 69 
CFA 3232.17 0.12 0.39 0.49 
CFA 2090.27 0.18 0.44 0.38 
CFA 356.00 0.14 0.57 0.29 
BR 559.90 0.13 0.57 0.30 
4 F R 58 
CFA 5529.99 0.17 0.41 0.52 
CFA 3740.76 0.13 0.38 0.49 
CFA 3770.06 0.09 0.42 0.49 
BR 5206.87 0.30 0.17 0.53 
5 M R 79 
CFA 281.01 0.20 0.54 0.27 
CFA 282.86 0.23 0.51 0.26 
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CFA 403.93 0.24 0.48 0.28 
CFA 248.43 0.28 0.41 0.32 
BR 4891.72 0.18 0.30 0.52 
6 M R 75 
DFA 185.08 0.09 0.75 0.16 
SFA 96.38 0.10 0.75 0.14 
7 M R 60 
CFA 3895.11 0.10 0.37 0.52 
CFA 53.95 0.11 0.70 0.19 
BR 1823.02 0.12 0.50 0.39 
BR 952.16 0.10 0.55 0.34 
SFA 424.33 0.10 0.70 0.20 
8 M R 77 
CFA 2255.24 0.17 0.41 0.42 
CFA 3594.29 0.14 0.38 0.49 
CFA 1818.38 0.16 0.45 0.39 
BR 3178.87 0.08 0.47 0.45 
DFA 1663.68 0.09 0.58 0.34 
9 M L 69 
CFA 5441.07 0.11 0.39 0.50 
CFA 3587.80 0.13 0.42 0.45 
BR 5195.27 0.07 0.45 0.47 
DFA 2368.55 0.11 0.54 0.36 
SFA 2546.64 0.08 0.47 0.42 
10 M R 75 
CFA 1412.76 0.11 0.49 0.40 
CFA 5135.10 0.10 0.45 0.46 
BR 6778.46 0.06 0.36 0.64 
SFA 3523.41 0.13 0.48 0.40 
3.1 Mechanical Properties 
Figure 4 displays box plots of the toughness values grouped by patient (a) and location (b). 
As can be seen, a large amount of inter and intra sample variance exists regarding patients 
and location. No statistically significant difference is observed between the mean toughness 
values of plaque sections grouped by patient or location (All p values > 0.05 following 
Bonferroni correction). 
Figure 4: Box plots depicting the toughness values grouped by patient (a) and location (b). The lines within the 
boxplots represent the median value of the data, the boxes encompass 50% of the data and the protruding bars 
encompass the remainder of the data with the exception of outliers which are depicted with asterisks. 
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3.2 Composition Parameters 
Figure 5 displays box plots depicting the composition parameters of the plaque tissue 
grouped by patient (a) and location (b). Again, a large amount of inter and intra sample 
variance exists regarding patients and location. 
Figure 5: Box plots of the composition parameters of each plaque section represented as a ratio of total measurable 
content grouped by patient (a) and location (b). In this figure red represents lipid content; blue represents collagen 
content and green represents calcified content. The lines within the boxplots represent the median value of the data, 
the boxes encompass 50% of the data and the protruding bars encompass the remainder of the data with the 
exception of outliers which are depicted with circles or asterisks depending on the degree to which the outlier lies 
outside of the data. 
Table 2 displays the results of bivariate analysis between the measured toughness values and 
the composition parameters for each section tested in this study. In this table Pearson’s 
coefficient is a measure of the linear dependence between two variables whereby +1 
represents a completely positive correlation and -1 represents a completely negative 
correlation. Spearman’s rho is a measure of how well a montonic function describes the 
dependence between two variables whereby +1 represents a completely positive montonic 
function and -1 represents a completely negative montonic function. These results show that 
the strongest correlation exists between toughness and Ca:Tot. This parameters is therefore 
further examined to assess its suitability as a preoperative predictor of plaque fracture 
response. 
Table 2: Results of bivariate analysis revealing parametric Pearson’s correlation coefficients and non-parametric 
Spearman’s rho correlation coefficients to quantify the correlation between the composition parameters and the 
specimen toughness. Significant correlations are indicated with * p < 0.05 and *** p < 0.001. 
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Correlation Lip:Tot Col:Tot Ca:Tot 
Toughness 
Pearson's -0.388 -0.689 0.917 
p value 0.022* 0.001*** 0.001*** 
Spearman's rho -0.306 -0.735 0.949 
p value 0.039* 0.001*** 0.001*** 
3.3 Regression Analysis 
Figure 6 displays the quadratic regression model relating the composition parameter Ca:Tot 
to toughness for each plaque section grouped by patient (a) and location (b). The model 
demonstrates a relatively robust adjusted R2 value (R2 = 0.885, p < 0.001). This indicates that 
the composition parameter Ca:Tot may be an appropriate metric to preoperatively predict 
plaque fracture response to CBA. 
Figure 6: Quadratic regression model relating the composition parameter Ca:Tot to toughness grouped by patient (a) 
and location (b). 
3.4 Structural Morphology 
SEM analysis was performed to qualitatively examine the morphology of the tissue structure 
along the fracture surface. A number of sections were chosen to represent the toughest, 
moderately tough, and least tough plaque sections visible in Figure 6b. Three sections 
exhibiting toughness values greater than 4000 J/m2 were chosen to represent the toughest 
sections. Two sections exhibiting toughness values between 1000 and 3000 J/m2 were chosen 
to represent the moderately tough sections. Two sections exhibiting toughness values less 
than 1000 J/m2 were chosen to represent the least tough sections.  
Figure 7 displays the fracture surfaces of the sections that represent the toughest sections 
tested. Figure 7a depicts the fracture surface a plaque section from the CFA of patient 1 and 
shows several large nodules of calcification with sheared faces. Figure 7b portrays the 
abluminal aspect of a plaque section from the BR of patient 4 and shows a large area of 
calcified tissue along the fracture surface which is located along the upper most portion of the 
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section. Figure 7c displays the fracture surface of a plaque section from the BR of patient 5 
and again shows numerous calcified nodules in the fracture area. Figure 7d is a higher 
magnification image of the largest node from Figure 7c. All calcified tissue in Figure 7 was 
subjected to EDX analysis. Results confirmed the presence of calcium and phosphorous in 
the ratios of 2.17, 1.74, and 1.82 for the calcified structures in Figure 7a, b, and c respectively 
therefore indicating that the structures in Figure 7 are calcium-rich hydroxyapatite (Ca:P > 
1.67) [68]. 
Figure 7: SEM images of sections exhibiting toughness values greater than 4000 J/m2. (a) Several large nodules of 
calcification with sheared faces present in a plaque section from the CFA of patient 1. (b) The calcified abluminal 
aspect of a plaque section from the BR of patient 4. (c) The fracture line of a plaque section from the BR of patient 5 
showing numerous calcified nodules in the fracture surface. (d) Magnified view of the largest calcified node from (c). 
Figure 8 displays the fracture surfaces of the sections that represent the moderately tough 
sections tested. Figure 8a displays the fracture surface of a plaque section from the CFA of 
patient 2 which consists of a combination of fibrous tissue and calcified tissue. This point is 
further illustrated by Figure 8b which shows a magnified image of the combined presence of 
fibrous and calcified tissue along the fracture surface highlighting the shear faces of both 
tissues. Figure 8c and d display the fracture surface of a plaque section from the DFA of 
patient 2. Again, both fibrous (c) and calcified tissues (d) are present. 
Figure 8: SEM images of sections exhibiting toughness values ranging between 1000 and 3000 J/m2. (a) The fracture 
surface of a plaque section from the CFA from patient 2 which consists of a combination of fibrous tissue and 
calcified tissue. (b) A magnified image of (a) highlighting the shear faces of both tissues. (c) The fracture surface of a 
plaque section from the DFA from patient 2 showing both fibrous and (d) calcified tissues. 
Figure 9 displays the fracture surface of the sections that represent the least tough sections 
tested. Figure 9a displays the fracture surface of a plaque section from the CFA of patient 5 
which consists of entirely fibrous tissue. Figure 9b shows a magnified image of the tissue 
confirming the presence of fibrous and the absence of calcified tissue. Figure 9c depicts the 
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fracture surface of a plaque section from the CFA of patient 5 which consists almost entirely 
of fibrous tissue with the exception of a single calcified nodule as highlighted in (d). 
Figure 9: SEM images of sections exhibiting toughness values below 1000 J/m2. (a) The fracture surface of a plaque 
section from the CFA of patient 5 which consists entirely of fibrous tissue. (b) A magnified image of (a) confirming 
the presence of fibrous tissue and the absence of calcified tissue. (c) The fracture surface of a plaque section from the 
CFA of patient 5 which consists almost entirely of fibrous tissue with the exception of a single calcified nodule (d). 
4 Discussion 
The toughness of femoral atherosclerotic tissue is of pivotal importance to understanding the 
mechanism of luminal expansion during CBA of the peripheral vessels. Furthermore, the 
ability to relate toughness to the location of plaque sections, plaque composition and 
pathological inclusions would allow for the improvement of existing CBA technology and for 
the stratification of patient treatment based on the predicted response of the plaque tissue to 
CBA. This study attempts to bridge this knowledge gap by relating the location and 
composition of human atherosclerotic tissue harvested from the femoral arteries to the 
toughness of the tissue. 
Figure 4 highlights the inter patient and location variance present regarding the toughness of 
atherosclerotic femoral artery tissue. The mean toughness values for the ten patient vessels 
characterised in this study range from approximately 140 to 4560 J/m2 and the mean 
toughness values for the four vessel locations range from approximately 1330 to 3035 J/m2. 
This inter patient and location variance makes the design of a single CBA device to fit all 
lesions and locations difficult as certain lesions will require more energy to spilt the 
atherosclerotic potion of the vessel. Furthermore, Figure 4 illustrates that there is also a large 
amount of intra patient and location toughness variance. This further complicates the 
implementation of CBA in diseased femoral vessels as the device and procedure must be 
designed to induce a controlled cut in the toughest portion of the plaque. Failure to achieve 
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this will result in the displacement of excessively tough portions of the lesion and cause 
trauma to the adjacent arterial wall. Also, CBA devices that apply a level of expansion force 
far above the fracture threshold of less tough atherosclerotic tissue risk perforating the 
surrounding arterial wall. These factors must be considered prior to intervention as such 
incidents defeat the purpose of CBA which is designed to reduce vessel trauma and may also 
be responsible for the reported cases of arterial rupture and microsurgical blade fracture [41-
43]. Equally, the presence of atherosclerotic tissue exhibiting toughness values as low as 54 
J/m2 suggests that certain regions of target lesions require far less energy to induce and 
propagate a controlled cut. Identifying these regions preoperatively may avoid excessive 
cutting force in areas of low plaque toughness that could result in unintended fracture of the 
healthy arterial tissue. 
The composition of each plaque section was characterised in this study to identify its 
influence on the toughness of the tissue and also to investigate if any of the established 
composition parameters can be implemented as a preoperative tool to assess lesion suitability 
for CBA treatment based on the predicted toughness of the atherosclerotic tissue. It is 
possible to clinically determine the composition parameters characterised in this study as Tosi 
et al. have suggested that FTIR spectroscopy is ready to be developed into a catheter based 
technology [69]. Additionally, existing clinical imaging tools are currently capable of 
characterising the composition of atherosclerotic plaques. Calcified tissue fraction, fibrous 
tissue and lipid content can be identified by optical coherence topography [70, 71] and also 
by magnetic resonance imaging [72-74].  
Similarly to toughness, the composition of the plaque sections examined in this study 
demonstrates large inter patient and location variance, Figure 5. The plaque sections are 
predominantly fibrocalcific which is in agreement with studies that have previously 
characterised the composition of atherosclerotic tissue extracted from the femoral arteries 
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[75, 76]. The influence of composition on the toughness of the plaque samples is confirmed 
using bivariate analysis. This analysis reveals a significant positive correlation between 
calcified tissue content and toughness and also a significant negative correlation between 
collagen/lipid content and toughness. 
The negative correlation between collagen content (Col:Tot) and section toughness indicates 
that toughness decreases with increasing collagen content. This is contrary to findings of 
Purslow [77] which demonstrated increasing tissue toughness with increasing collagen 
content. The negative correlation observed in this study may occur as a result of the collagen 
and calcified tissue content being represented as a fraction of the total tissue content. This 
results in the two biological parameters correlating significantly with one another (r = -0.823, 
p < 0.001) as increasing calcified tissue content will decrease the recorded collagen and lipid 
content. 
The positive correlation present between toughness and Ca:Tot can be explained by the 
increasing presence of calcified tissue within the tested sections. Calcified femoral artery 
tissue has been shown to exhibit osteoid metaplasia suggesting that this tissue is not 
dissimilar from bone [75]. Bone exhibits a high work to fracture which is comparable to the 
toughness exhibited by the most heavily calcified sections characterised in this study [78]. 
Calcified arterial tissue can therefore be assumed to be much tougher than the native arterial 
tissue and closer in toughness to bone thus explaining the correlation between section 
toughness and calcified tissue content.  
Regression analysis reveals a significant relationship between calcified tissue content and 
tissue toughness. The resulting curve for the compiled section data also demonstrates that the 
tissue is relatively unaffected by the degree of plaque calcification up to a Ca:Tot value of 
approximately 0.32. After this point the tissue toughness increases substantially with 
increasing calcified tissue content. This may be occurring as the blade of the guillotine 
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cutting apparatus is initially capable of manoeuvring around the calcified tissue surrounding 
the fracture zone therefore allowing the blade to cut the less tough fibrous tissue. Beyond this 
point, the blade is forced to directly cut the increasingly calcified tissue and the resulting 
measurable toughness increases with a corresponding increase in calcified tissue content. 
This theory is supported by the evidence presented in SEM images that characterise the 
structural morphology of the fracture areas of a number of sections. Images of the toughest 
sections characterised display numerous calcified structures exhibiting shear faces, Figure 7. 
This suggests that the calcified tissue was cut as part of the guillotine tests that characterised 
these samples and that the resulting toughness values are indicative of the calcified tissue 
rather than the surrounding tissue. Furthermore, the Ca:P identified during EDX analysis of 
the calcified tissues located in three of the toughest sections characterised in this study are 
inversely proportional to toughness, an observation previously made in pure hydroxyapatite 
[68]. This may account for the variance in toughness observed in the tougher sections 
characterised in this study despite these sections exhibiting relatively constant Ca:Tot values 
indicating constant calcified tissue content. 
SEM imaging may also explain the relationship between calcified tissue and toughness in the 
moderately tough and least tough sections. The moderately tough sections display primarily 
fibrous tissue with some calcified tissue that has been subjected to cutting as evidenced by 
shear faces, Figure 8. This suggests that the toughness exhibited by the sections is a result of 
the combined response of fibrous and calcified tissue. It is likely that the calcified tissue 
content influences the toughness response more than the fibrous tissue as these moderately 
tough sections still exhibit toughness values higher than those observed for healthy porcine 
aortic tissue (290 J/m2) [58] which is the response of collagen fibres embedded in a tissue 
matrix. The least tough group display fracture surfaces consisting almost entirely of fibrous 
tissue suggesting that the relatively low toughness values exhibited are a result of collagen 
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cleavage. The presence of isolated calcified nodules in Figure 9d may explain the presence of 
the apparent outlier in Figure 6d  that displays a Ca:Tot value in excess of 0.3 yet registers a 
decrease in toughness relative to sections with a lower Ca:Tot value. 
The significant correlations and regression models generated in this study indicate that the 
composition parameter Ca:Tot may be an effective tool for tailoring CBA approach prior to 
intervention. Such a tool may lead to a reduction in clinically observed complications, an 
improvement in trial results and an increased adoption of the CBA technique to reduce vessel 
trauma and further endovascular treatment uptake. 
A limitation of this study is that a variable number of sections are obtained from each patient. 
Due to this, the influence of patient specific factors cannot be neglected from the regression 
analysis. However, as the influence of plaque composition is consistent throughout each 
plaque section (as indicated by the robust R2 values), it is assumed that the influence of 
patient specific factors is negligible compared to the influence of plaque composition. An 
additional limitation is the absence of a suitable healthy femoral artery tissue control. 
Comparisons drawn between plaque tissue and healthy porcine aortic tissue may not be 
entirely appropriate due to location and species differences. However, no data on the 
toughness of human arterial tissue in health or disease currently exists in literature. In 
addition to this, the acquisition of healthy human femoral arterial tissue is difficult as samples 
need to be explanted during autopsy of relatively young patients to ensure the absence of 
atherosclerosis. As this study does not have ethical approval to obtain healthy femoral arterial 
tissue from autopsy, comparisons are drawn to healthy porcine aortic tissue as a control. 
5 Conclusions 
This study characterises the toughness of atherosclerotic femoral tissue in terms of critical 
energy release rate and observes no statistically significant difference between mean 
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toughness and patient or location. The resulting toughness values range far above and below 
the values reported for healthy porcine arterial tissue. This highlights the challenges faced by 
CBA intervention and the need to classify lesion type preoperatively to insure optimal results. 
The composition of each sample is also characterised in an attempt to develop a lesion 
classifier and the composition parameter depicting the calcified content of the plaque displays 
significant correlation with the measured toughness. SEM imaging supports this correlation 
by revealing the presence of large regions of calcified tissue in the toughest sections that are 
absent from the least tough sections. Regression analysis further demonstrates the predictive 
power of this parameter and the potential for it to be employed as a preoperative predictor of 
target lesion response to CBA treatment. Such a tool may lead to a reduction in clinically 
observed complications, an improvement in trial results, and an increased adoption of the 
CBA technique to reduce vessel trauma and further endovascular treatment uptake. 
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